Results for “General Clarke”

because you really tried to convey to a general

Harvard Law School. Fmr Acting AsstU.S. Attorney General in the Office of

the inspector general found that the “senior CIA

and the general public will not be willing to consider

be deemed to own an undivided interest in the assets of KUE or the General

due to the fact that they force choices. Creating an architecture for human-like general

the General Partner intends to approve transfers of Units to an affiliate of the Investor in

the General Partner intends to approve transfers of the

” or “what General Motors is trying to do

…the 2005 reauthorization to include after “Secretary of Health and Human Services”, “in collaboration with the Attorney General and the Secretary of Homeland Security,” Subsection 203(c) should be likewise amended. The Office of Management and Budget has advised that there is no...

The council would have a president, or secretary general, an entire staff and premises allocated by the Iraqi government in Baghdad. The council will also have its own budget, which is yet to be determined but will equal that of the premiership, the parliamentary speaker and the...

…al to keep the voters' attention during what will be a raucous Democratic primary season. Rules governing access to the general election debate stage dictate that a candidate enjoy support of at least 15% of voters in the months leading up to the general election. • This dream ca...

… NSA’s need to create new bureaucratic mechanism to monitor its compliance with FISA court orders, Rajesh De, the NSA’s General Counsel at the time of the Snowden breach, described the NSA as becoming by 2013 “one of the most regulated enterprises in the world.” Grafted onto its...

…rdeau book states that the FBI is violating the law with this cover-up. The book says President Obama told the Attorney General that Jeffrey Epstein was cooperating in an overseas banking crime, but HOUSE OVERSIGHT 031193 the FBI can't arrest Epstein. These are all lies by the Pr...

… robust product pipelines based on stem cell therapies. However, a tougher regulatory climate for biopharmaceuticals in general and a protracted legal challenge to the relaxing of rules on hESCs has served to keep both big pharma companies and venture capitalists on the sidelines...